Medpace (MEDP) shares fell 3.2% on Wednesday after Baird downgraded the stock to neutral from outperform and adjusted its price target to $547 per share from $477.
Trading volume stood at around 230,600 shares compared with a daily average of 375,188.
Price: $528.74, Change: $-17.55, Percent Change: -3.21%